Latest news from Absorption Pharmaceuticals on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/absorption-pharmaceuticals-to-receive-patent-for-premature-ejaculation-topical-medication/?sc=rsin /articles/absorption-pharmaceuticals-to-receive-patent-for-premature-ejaculation-topical-medication/?sc=rsin Mon, 29 Apr 2013 09:05:00 EST Absorption Pharmaceuticals announced today that the U.S. Patent and Trademark Office has indicated that it will grant a patent related to the use of its topical medication, Promescent, for premature ejaculation (PE). The patent protects novel lidocaine-only eutectic formulation which enables maximum absorption of the anesthetic through the skin's outer layer and provides men with improved ejaculatory control while maintaining great sensory feeling. Absorption Pharmaceuticals